330 related articles for article (PubMed ID: 16380465)
1. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
[TBL] [Abstract][Full Text] [Related]
2. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
[TBL] [Abstract][Full Text] [Related]
4. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
[TBL] [Abstract][Full Text] [Related]
5. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
6. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
[TBL] [Abstract][Full Text] [Related]
7. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
8. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
[TBL] [Abstract][Full Text] [Related]
9. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats.
Liu BC; Huang HQ; Luo DD; Ma KL; Liu DG; Liu H
Chin Med J (Engl); 2006 Jun; 119(12):1010-6. PubMed ID: 16805985
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
Riser BL; Cortes P
Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
[TBL] [Abstract][Full Text] [Related]
13. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
[TBL] [Abstract][Full Text] [Related]
15. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
[TBL] [Abstract][Full Text] [Related]
18. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
[TBL] [Abstract][Full Text] [Related]
19. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G
Diabetes; 2010 Apr; 59(4):1046-54. PubMed ID: 20068137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
